XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.540
-0.130 (-4.87%)
At close: May 8, 2026, 4:00 PM EDT
2.612
+0.072 (2.83%)
After-hours: May 8, 2026, 7:24 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.85 million as of May 8, 2026. Its market cap has decreased by -53.12% in one year.
Market Cap
6.85M
Enterprise Value
6.65M
1-Year Change
-53.12%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $6.85M, a decrease of -96.19%. That is a compound annual growth rate of -14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 6.85M | -3.78% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 7.35M |
| Processa Pharmaceuticals | 7.26M |
| Addex Therapeutics | 7.08M |
| Akari Therapeutics, | 7.07M |
| Xenetic Biosciences | 7.03M |
| Immuron | 6.86M |
| Aptorum Group | 6.84M |
| TransCode Therapeutics | 6.71M |